← Back to Briefing
AI's Role in Accelerating Drug Discovery and Mitigating Costs
Importance: 78/1001 Sources
Why It Matters
The escalating costs and timelines in drug development threaten innovation and market competitiveness, making AI a crucial tool for transforming the pharmaceutical industry.
Key Intelligence
- ■Drug discovery remains a high-cost, high-risk process, with development expenses doubling approximately every nine years (Eroom's Law).
- ■Bringing a new pharmaceutical to market typically spans 10-15 years, requiring substantial investment.
- ■The pharmaceutical market heavily favors first-movers, increasing pressure to innovate faster and more efficiently.
- ■AI-driven approaches are being explored to 'close the data loop' and streamline the drug discovery pipeline.